Oracle Investment Management’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-48,540
Closed -$242K 34
2022
Q4
$242K Hold
48,540
0.2% 20
2022
Q3
$271K Hold
48,540
0.15% 20
2022
Q2
$428K Sell
48,540
-92,583
-66% -$940K 0.13% 23
2022
Q1
$2.2M Sell
141,123
-228,683
-62% -$3.96M 0.44% 18
2021
Q4
$9.82M Sell
369,806
-206,667
-36% -$7.84M 1.4% 12
2021
Q3
$28.1M Hold
576,473
3.5% 7
2021
Q2
$48.6M Hold
576,473
6.7% 5
2021
Q1
$58.4M Hold
576,473
8.74% 3
2020
Q4
$58M Sell
576,473
-45
-0% -$3K 7.27% 3
2020
Q3
$26.7M Sell
576,518
-109,388
-16% -$5.61M 3.52% 6
2020
Q2
$39.5M Buy
+685,906
New +$45.8M 5.01% 5

Other funds holding AWH

Oracle Investment Management's AWH Position: Q1 2023 in Review

Oracle Investment Management sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q1 2023, closing a stake of 48,540 shares — an estimated $242K sold.

Oracle Investment Management first reported a position in AWH in Q2 2020 and held it in 11 quarters. The position peaked at $58.4M in Q1 2021. 45 funds tracked by Wall St. Rank hold AWH as of Q1 2023.

  • Oracle Investment Management reported no remaining Aspira Women's Health Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Oracle Investment Management sold 48,540 Aspira Women's Health Inc. Common Stock shares in Q1 2023, an estimated $242K.
  • Oracle Investment Management first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 11 quarters.
  • Oracle Investment Management's Aspira Women's Health Inc. Common Stock position peaked at $58.4M in Q1 2021.
  • 45 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q1 2023.

Based on Oracle Investment Management's 13F filing for Q1 2023, filed 15 May 2023.